{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:05:48Z","timestamp":1792688748680,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.canep.2015.07.008","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T23:03:45Z","timestamp":1438297425000},"page":"682-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["PAX1 methylation as an auxiliary biomarker for cervical cancer screening: A meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Christos","family":"Nikolaidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Nena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Panagopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Balgkouranidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makrina","family":"Karaglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Chatzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Agorastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros C.","family":"Constantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2015.07.008_bib0200","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0205","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ygyno.2012.09.004","article-title":"Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period","volume":"127","author":"Chen","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/OGX.0b013e3182732375","article-title":"Cervical cancer screening in high- and low-resource countries: implications and new developments","volume":"67","author":"Hoppenot","year":"2012","journal-title":"Obstet Gynecol Surv."},{"key":"10.1016\/j.canep.2015.07.008_bib0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e318282b982","article-title":"The evolution of the Papanicolaou smear","volume":"56","author":"Tambouret","year":"2013","journal-title":"Clin Obstet Gynecol."},{"key":"10.1016\/j.canep.2015.07.008_bib0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1749-6632.2010.05661.x","article-title":"Can HPV testing replace the pap smear?","volume":"1205","author":"Agorastos","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.canep.2015.07.008_bib0230","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.vaccine.2009.09.097","article-title":"Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far","volume":"27","author":"Agorastos","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.canep.2015.07.008_bib0235","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/IGC.0b013e3181ca5df3","article-title":"Effect of type-specific human papillomavirus incidence on screening performance and cost","volume":"20","author":"Agorastos","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology."},{"key":"10.1016\/j.canep.2015.07.008_bib0245","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.ygyno.2007.08.080","article-title":"Bayesian meta-analysis of Papanicolaou smear accuracy","volume":"107","author":"Cong","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0250","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.canep.2015.07.008_bib0255","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.canep.2015.07.008_bib0260","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","article-title":"Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies","volume":"104","author":"Koliopoulos","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.28640","article-title":"Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials","volume":"135","author":"Pileggi","year":"2014","journal-title":"Int J Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0270","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.26194","article-title":"Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy","volume":"130","author":"Porras","year":"2012","journal-title":"Int J Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0275","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","article-title":"Susceptibility to cervical cancer: an overview","volume":"126","author":"de Freitas","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0280","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/onc.2011.121","article-title":"Histone onco-modifications","volume":"30","author":"Fullgrabe","year":"2011","journal-title":"Oncogene."},{"key":"10.1016\/j.canep.2015.07.008_bib0285","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.canep.2015.07.008_bib0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/IGC.0000000000000054","article-title":"High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma","volume":"24","author":"Chang","year":"2014","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0295","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/1476-4598-13-257","article-title":"SOX1 Down-regulates beta-catenin and Reverses Malignant Phenotype in Nasopharyngeal Carcinoma","volume":"13","author":"Guan","year":"2014","journal-title":"Mol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0300","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1525-1438.2006.00522.x","article-title":"Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics","volume":"16","author":"Jeong","year":"2006","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dc.21758","article-title":"Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1)","volume":"41","author":"Chao","year":"2013","journal-title":"Diagn Cytopathol."},{"key":"10.1016\/j.canep.2015.07.008_bib0310","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","article-title":"PAX1 methylation as a potential biomarker for cervical cancer screening","volume":"24","author":"Kan","year":"2014","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0315","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/cam4.253","article-title":"PAX1\/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study","volume":"3","author":"Lai","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.canep.2015.07.008_bib0320","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2010.07.028","article-title":"Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy","volume":"119","author":"Lim","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.canep.2015.07.008_bib0325","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7314\/APJCP.2014.15.2.891","article-title":"PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev."},{"key":"10.1016\/j.canep.2015.07.008_bib0330","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.canep.2015.07.008_bib0335","unstructured":"reviews CCChfdta."},{"key":"10.1016\/j.canep.2015.07.008_bib0340","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.canep.2015.07.008_bib0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/sim.2992","article-title":"We should not pool diagnostic likelihood ratios in systematic reviews","volume":"27","author":"Zwinderman","year":"2008","journal-title":"Stat Med."},{"key":"10.1016\/j.canep.2015.07.008_bib0350","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0355","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1002\/cncr.25252","article-title":"Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse","volume":"116","author":"Lai","year":"2010","journal-title":"Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.07.036","article-title":"Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results","volume":"204","author":"Lin","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.canep.2015.07.008_bib0370","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","article-title":"Systematic reviews of diagnostic test accuracy","volume":"149","author":"Leeflang","year":"2008","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.canep.2015.07.008_bib0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ."},{"key":"10.1016\/j.canep.2015.07.008_bib0380","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome - biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.canep.2015.07.008_bib0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-61779-612-8_9","article-title":"DNA methylation changes in cervical cancers","volume":"863","author":"Lu","year":"2012","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.canep.2015.07.008_bib0390","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Natl Cancer Inst."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T10:30:34Z","timestamp":1537439434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782115001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1877782115001605"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2015.07.008","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX1 methylation as an auxiliary biomarker for cervical cancer screening: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2015.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}